Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.

Knudsen S, Biering-Sørensen B, Kornum BR, Petersen ER, Ibsen JD, Gammeltoft S, Mignot E, Jennum PJ.

Neurology. 2012 Jul 3;79(1):102-3. doi: 10.1212/WNL.0b013e31825dce03. Epub 2012 Jun 20. No abstract available.

PMID:
22722630
2.

[Narcolepsy as an autoimmune disease].

Sarkanen T, Vaarala O, Julkunen I, Partinen M.

Duodecim. 2015;131(12):1153-60. Review. Finnish.

PMID:
26245045
3.

Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.

Knudsen S, Gammeltoft S, Jennum PJ.

Brain. 2010 Feb;133(Pt 2):568-79. doi: 10.1093/brain/awp320. Epub 2010 Feb 3.

PMID:
20129934
4.

Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.

Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M.

Neurology. 2009 Oct 20;73(16):1333-4. doi: 10.1212/WNL.0b013e3181bd1344. No abstract available.

PMID:
19841387
5.

Narcolepsy after A/H1N1 vaccination.

Mendes MF, Valladares Neto Dde C, Azevedo RA, Caramelli P.

Clinics (Sao Paulo). 2012;67(1):77-8. No abstract available. Erratum in: Clinics (Sao Paulo). 2012;67(5):541.

6.

The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.

Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ.

Sleep Med. 2011 Jan;12(1):12-8. doi: 10.1016/j.sleep.2010.05.010. Epub 2010 Dec 8.

PMID:
21145280
7.

A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.

Dauvilliers Y, Maret S, Bassetti C, Carlander B, Billiard M, Touchon J, Tafti M.

Neurology. 2004 Jun 8;62(11):2137-8. No abstract available.

PMID:
15184641
8.

Molecular genetics and treatment of narcolepsy.

Dauvilliers Y, Tafti M.

Ann Med. 2006;38(4):252-62. Review.

PMID:
16754256
9.

Immunology. Swine flu connection provides clues about narcolepsy.

Vogel G.

Science. 2013 Dec 20;342(6165):1430. doi: 10.1126/science.342.6165.1430. No abstract available.

PMID:
24357283
10.

Immunology. Key narcolepsy-influenza vaccine findings retracted.

Underwood E.

Science. 2014 Aug 1;345(6196):498. doi: 10.1126/science.345.6196.498. No abstract available.

PMID:
25082675
11.

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain.

Kornum BR, Faraco J, Mignot E.

Curr Opin Neurobiol. 2011 Dec;21(6):897-903. doi: 10.1016/j.conb.2011.09.003. Epub 2011 Sep 30. Review.

PMID:
21963829
12.

The hypocretin/orexin system in health and disease.

Nishino S.

Biol Psychiatry. 2003 Jul 15;54(2):87-95. Review. Erratum in: Biol Psychiatry. 2003 Jul 15;54(2):175.

PMID:
12873797
13.

Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy.

Knudsen S, Mikkelsen JD, Bang B, Gammeltoft S, Jennum PJ.

Neuropediatrics. 2010 Oct;41(5):217-22. doi: 10.1055/s-0030-1267993. Epub 2011 Jan 5.

PMID:
21210337
14.

[Narcolepsy: a new perspective on diagnosis and treatment].

Fronczek R, van der Zande WL, van Dijk JG, Overeem S, Lammers GJ.

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):856-61. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1260.

PMID:
17472116
15.

Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men.

Donjacour CE, Kalsbeek A, Overeem S, Lammers GJ, Pévet P, Bothorel B, Pijl H, Aziz NA.

Chronobiol Int. 2012 Apr;29(3):356-62. doi: 10.3109/07420528.2012.655869.

PMID:
22390248
16.

Hypocretin administration as a treatment for human narcolepsy.

Siegel JM.

Sleep. 2003 Dec 15;26(8):932-3. No abstract available.

PMID:
14746368
17.

Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level.

Dauvilliers Y, Abril B, Charif M, Quittet P, Bauchet L, Carlander B, Touchon J.

Neurology. 2007 Sep 18;69(12):1300-1. No abstract available.

PMID:
17875919
18.

[Hypocretin (orexin) deficiency in narcolepsy-cataplexy].

Nevsímalová S, Vanková J, Sonka K, Faraco J, Rogers W, Overeem S, Mignot E.

Sb Lek. 2000;101(4):381-6. Czech.

PMID:
11702580
19.

Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.

Fujiki N, Nishino S.

CNS Neurol Disord Drug Targets. 2007 Feb;6(1):45-62. Review.

PMID:
17305553
20.

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M.

Cell. 1999 Aug 20;98(4):437-51.

Supplemental Content

Support Center